PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males
Clinical trial NCT04237129 · COMPLETED
Trial details
- NCT number
- NCT04237129
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-27
- Primary completion
- 2019-12-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.